LONDON
A US cattle-breeding and biotechnology company last week announced its success in cloning a bull calf, called Gene, using primordial stem cells from a 30-day-old calf fetus. The cloning of Dolly — a transgenic lamb — differed in that the cells were taken from an adult sheep.
ABS Global, based in Wisconsin, also announced plans to set up a new subsidiary, Infigen, to commercialize the technologies. It claims its process could provide an efficient way of producing large numbers of cloned cattle. The cloning technologies could “offer tremendous promise for enhancing the quality, consistency and nutritional value of dairy and beef products,” says Marc van't Noordende, ABS chief executive.
Rights and permissions
About this article
Cite this article
After Dolly, meet Gene, the cloned calf. Nature 388, 611 (1997). https://doi.org/10.1038/41616
Issue Date:
DOI: https://doi.org/10.1038/41616
